NAZOPHYL DARVA 177.45 MG / 30 G
MENTHOL : 177.45 MG / 30 G THYMOL : 27.95 MG / 30 G CAMPHOR : 247 MG / 30 G METHYL SALICYLATE : .0195 ML / 30 G METHYLENE BLUE : .1014 MG / 30 G EUCALYPTOL : .066 ML / 30 G OIL OF CAJEPUT : .039 ML / 30 G · DIN 00166375 · PRODUITS FRANCAIS LABS INC.
Health Canada status: CANCELLED POST MARKET
What is NAZOPHYL DARVA?
NAZOPHYL DARVA 177.45 MG / 30 G contains MENTHOL : 177.45 MG / 30 G THYMOL : 27.95 MG / 30 G CAMPHOR : 247 MG / 30 G METHYL SALICYLATE : .0195 ML / 30 G METHYLENE BLUE : .1014 MG / 30 G EUCALYPTOL : .066 ML / 30 G OIL OF CAJEPUT : .039 ML / 30 G. It is listed in the Health Canada Drug Product Database under DIN 00166375, held by PRODUITS FRANCAIS LABS INC., supplied as OINTMENT for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 30-May-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00166375 |
|---|---|
| Brand name | NAZOPHYL DARVA |
| Generic / active ingredient | MENTHOL : 177.45 MG / 30 G THYMOL : 27.95 MG / 30 G CAMPHOR : 247 MG / 30 G METHYL SALICYLATE : .0195 ML / 30 G METHYLENE BLUE : .1014 MG / 30 G EUCALYPTOL : .066 ML / 30 G OIL OF CAJEPUT : .039 ML / 30 G |
| Manufacturer | PRODUITS FRANCAIS LABS INC. |
| Strength | 177.45 MG / 30 G |
| Dosage form | OINTMENT |
| Route of administration | NASAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R05X OTHER COLD PREPARATIONS |
| AHFS class | 20:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-May-1997 |
| Original market date | 1930-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R05X OTHER COLD PREPARATIONS. 0 of 101 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BEECH NUT BLACK COUGH DROP | 0.23 MG | LOZENGE | BETA BRANDS LIMITED | CANCELLED POST MARKET | DIN 02230544 |
| BEECH NUT BLACK COUGH DROPS | 3.9 MG | LOZENGE | LIFE SAVERS CANADA, DIVISION OF HERSHEY CANADA INC. | CANCELLED POST MARKET | DIN 00373508 |
| BEECH NUT HONEY LEMON COUGH DROP | 0.35 MG | LOZENGE | BETA BRANDS LIMITED | CANCELLED POST MARKET | DIN 02230549 |
| BEECH NUT HONEY LEMON COUGH DROPS | .35 MG | LOZENGE | NABISCO BRANDS LTD. | CANCELLED POST MARKET | DIN 00631612 |
| BEECH NUT MENTHOL COUGH DROP | 1.3 MG | LOZENGE | BETA BRANDS LIMITED | CANCELLED POST MARKET | DIN 02230548 |
| BEECH NUT WILD CHERRY COUGH DPS | .35 MG | LOZENGE | LIFE SAVERS CANADA, DIVISION OF HERSHEY CANADA INC. | CANCELLED POST MARKET | DIN 00373486 |
| BEECH NUT WILD CHERRY COUGH DROP | 1.88 MG | LOZENGE | BETA BRANDS LIMITED | CANCELLED POST MARKET | DIN 02230547 |
| BEECH-NUT MENTHOL COUGH DROPS | 5.1 MG | LOZENGE | LIFE SAVERS CANADA, DIVISION OF HERSHEY CANADA INC. | CANCELLED POST MARKET | DIN 00373494 |
| BENTASIL CHERRY | 2 MG | LOZENGE | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 02230937 |
| BENTASIL EXTRA STRENGTH EUCALYPTUS | 5.7 MG | LOZENGE | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 02240046 |
Who else supplies OTHER COLD PREPARATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER COLD PREPARATIONS appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.